
Ifomid M 400mg/2gm Injection
Marketer
United Biotech Pvt Ltd
Salt Composition
Mesna (400mg) + Ifosfamide (2gm)
Overview Ifomid M 400mg/2gm Injection
This prescription medication, Ifomid M 400mg/2gm Injection, combines two cancer-fighting agents to inhibit tumor growth and proliferation. Administered only by a healthcare provider, self-injection is strictly prohibited. Report any allergies to this medication to your physician immediately. Potential side effects include nausea, vomiting, alopecia, anemia, and leukopenia. Blood tests may be required before and during treatment, and supplementary therapy might be necessary to address any medication-induced deficiencies. A balanced diet rich in fruits and vegetables is also recommended. Disclose all other medications, pregnancies, breastfeeding, or existing health conditions to your doctor. Alcohol consumption should be avoided during treatment, and operating machinery or driving is discouraged.
Primary Ingredients of Ifomid M 400mg/2gm Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Ifomid M 400mg/2gm Injection
Malignancy
Major Benefits of Ifomid M 400mg/2gm Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Ifomid M 400mg/2gm Injection:
- Hair loss
- Nausea
- Vomiting
- Anemia (low number of red blood cells)
- Blood in urine
- Decreased white blood cell count
- Increased risk of infection
- Neurotoxicity
How to use Ifomid M 400mg/2gm Injection:
Administering this medication will be performed by your healthcare provider. Self-medication is strictly prohibited.
How Ifomid M 400mg/2gm Injection works:
Ifosfamide and Mesna Injection (Ifomid M 400mg/2gm) unites two distinct agents. Ifosfamide, a cytoprotective drug, mitigates bladder toxicity associated with the other component, Mesna. Mesna, an anti-neoplastic agent, directly interferes with cancer cell DNA, thus inhibiting their proliferation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Ifomid M 400mg/2gm Injection is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Using Ifomid M 400mg/2gm Injection during pregnancy poses a confirmed risk to the fetus. Its use is contraindicated except in exceptional, life-threatening circumstances where potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Breastfeeding mothers should not use Ifomid M 400mg/2gm Injection. Evidence indicates potential harm to the infant from this medication.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Ifomid M 400mg/2gm Injection.
KidneyCAUTION
Patients with kidney impairment should receive Ifomid M 400mg/2gm Injection with close monitoring. Dosage modification of Ifomid M 400mg/2gm Injection may be necessary; physician consultation is advised.
LiverCAUTION
Lenalidomide 400mg/2gm injection requires careful administration in individuals with hepatic impairment. Dosage modification of lenalidomide 400mg/2gm injection might be necessary. Physician consultation is advised.
What if you forget to take Ifomid M 400mg/2gm Injection :
Should you forget a scheduled dose of Ifomid M 400mg/2gm Injection, seek your physician's advice.
Facts to Know About Ifomid M 400mg/2gm Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
